Article Details
Retrieved on: 2024-03-25 21:08:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AbbVie is acquiring Landos Biopharma, whose lead drug is a small molecule that takes a novel approach to treating ulcerative colitis.
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here